Skip to content

Examination of postprandial urinary salt excretion during test food intake for adult males

Examination of postprandial urinary salt excretion during test food intake for adult males - Examination of postprandial urinary salt excretion during test food intake for adult males

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000042221
Enrollment
16
Registered
2021-11-27
Start date
2020-10-26
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult

Interventions

Intake of test food for 2 consecutive weeks Intake of placebo food for 2 consecutive weeks

Sponsors

TTC Co., Ltd
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: (1) Healthy males from 20 to 64 years of age (2) Subjects with systolic blood pressure of 130 mmHg to 159 mmHg and / or diastolic blood pressure of 85 mmHg to 99 mmHg

Exclusion criteria

Exclusion criteria: (1) Subjects who are going to the hospital or taking medication for the treatment of dysuria (2) Subjects who are on or will be on a diet during the study period (3) Subjects with excessive drinking habits (4) Subjects who habitually take health foods, quasi-drugs, and medicines that have a blood pressure lowering effect (5) Subjects with smoking habits (6) Subjects currently diagnosed with arrhythmia (7) Subjects who take health foods, quasi-drugs, and medicines that strengthen the ingredients involved in research foods at least once a week (8) Subjects who take health foods, quasi-drugs, and medicines that are said to be effective in salt excretion at least once a week (9) Subjects with or with renal disease, urethral stones (10) Subjects having a disease requiring treatment or a history of serious diseases for which medication was required (11) Subjects having a disease requiring treatment or a history of serious diseases for which medication was required (12) Subjects having possibilities for emerging allergy related to the study (13) Subjects whose physical measurements and physical examination values before the start of ingestion were significantly out of the standard range (14) Subjects who have participated in other clinical study within the last one month prior to the current study or are planned to participate in other clinical study after informed consent for the current study (15) Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire (16) Subjects judged as unsuitable for the study by the investigator for other reasons

Design outcomes

Primary

MeasureTime frame
Urinary salt excretion at 2 weeks ingestion

Secondary

MeasureTime frame
1. Total Body Water 2. blood pressure 3. QOL Questionnaire

Countries

Japan

Contacts

Public ContactShinsuke Tsuji

TTC Co., Ltd. Clinical Research Planning Department

s.tsuji@ttc-tokyo.co.jp03-5459-5329

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026